RWP
NMTR

RWA Wealth Partners’s 9 Meters Biopharma NMTR Stock Holding History

RWA Wealth Partners’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,429
Closed -$48.9K – 270
2022
Q4 		$48.9K Buy
21,429
+7,488
+54% +$17.1K ﹤0.01% 256
2022
Q3 		$60K Sell
13,941
-371
-3% -$1.84K ﹤0.01% 239
2022
Q2 		$75K Buy
14,312
+2,768
+24% +$26.1K 0.01% 237
2022
Q1 		$138K Buy
11,544
+8,346
+261% +$114K 0.01% 248
2021
Q4 		$63K Buy
+3,198
New +$71.5K ﹤0.01% 244

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RWA Wealth Partners's NMTR Position: Q1 2023 in Review

RWA Wealth Partners sold out of 9 Meters Biopharma (NMTR) in Q1 2023, closing a stake of 21,429 shares — an estimated $48.9K sold.

RWA Wealth Partners first reported a position in NMTR in Q4 2021 and held it in 5 quarters. The position peaked at $138K in Q1 2022. 39 funds tracked by Wall St. Rank hold NMTR as of Q1 2023.

  • RWA Wealth Partners reported no remaining 9 Meters Biopharma position as of Q1 2023 after selling out during the quarter.
  • RWA Wealth Partners sold 21,429 9 Meters Biopharma shares in Q1 2023, an estimated $48.9K.
  • RWA Wealth Partners first reported a position in 9 Meters Biopharma in Q4 2021 and held it in 5 quarters.
  • RWA Wealth Partners's 9 Meters Biopharma position peaked at $138K in Q1 2022.
  • 39 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q1 2023.

Based on RWA Wealth Partners's 13F filing for Q1 2023, filed 26 Apr 2023.